Clinical Trials for Lymphoma

Find clinical trials for lymphoma. Discover research opportunities and treatment options in your area.

232 Active Trials Found

Showing 232 trials on this page

Page 4 of 12

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

NCT ID: NCT05618041

This clinical trial is studying a new treatment called CAR-T cell therapy for patients with certain types of blood cancers, including acute lymphoblastic leukemia, lymphoma, and multiple myeloma. C...

Recruiting

Phase: NA Type: interventional Locations: Taiyuan, Shanxi, China, Taiyuan, Shanxi, China +1 more

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

NCT ID: NCT06550427

This clinical trial is studying a new way to evaluate how well treatments are working for patients with aggressive B-cell lymphoma, specifically a type called large B-cell lymphoma (LBCL). The rese...

Recruiting

Type: observational Locations: Taipei, , Taiwan

Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV

NCT ID: NCT07032103

This clinical trial is studying patients who have been diagnosed with aggressive types of lymphoma, which is a cancer of the lymphatic system. This includes both Hodgkin lymphoma and non-Hodgkin ly...

Recruiting

Type: observational Locations: Seoul, , Korea, Republic Of

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.

NCT ID: NCT06137144

This clinical trial is studying a new medication called AZD3470, both on its own and when combined with other cancer treatments, for patients with certain types of blood cancers, specifically lymph...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Boston, Massachusetts, United States +18 more

Study of CAR-T Therapy in Older Patients

NCT ID: NCT04300998

This clinical trial is studying how older patients respond to a special type of treatment called CAR-T cell therapy for certain types of blood cancers, including lymphoma and multiple myeloma. The ...

Recruiting

Type: observational Locations: New York, New York, United States, New York, New York, United States

The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease

NCT ID: NCT06795815

This clinical trial, called "The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco-Hematologic Disease," is studying how a special card game can help patients with serious...

Recruiting

Phase: NA Type: interventional Locations: Reggio Emilia, , Italy

Clonal Hematopoiesis of Immunological Significance

NCT ID: NCT05969821

This clinical trial, titled "Clonal Hematopoiesis of Immunological Significance," is focused on understanding certain immune system diseases and conditions, particularly those linked to a syndrome ...

Not yet recruiting

Type: observational

Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis

NCT ID: NCT05898477

This clinical trial is focused on understanding a serious condition called Hemophagocytic Lymphohistiocytosis (HLH) that can occur in patients with lymphoma, a type of cancer that affects the lymph...

Recruiting

Type: observational Locations: Birmingham, Alabama, United States

Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy

NCT ID: NCT06895538

This clinical trial is studying the effects of a treatment called rabbit anti-human T-lymphocyte immunoglobulin (ATLG) compared to another treatment called anti-thymocyte globulin (ATG) for patient...

Recruiting

Type: observational Locations: Beijing, , China

A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy

NCT ID: NCT05464719

This clinical trial is studying a treatment called loncastuximab tesirine (often shortened to "lonca") to see if it can help control large B-cell lymphoma in patients who have had a partial respons...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study

NCT ID: NCT04957901

This clinical trial is studying the use of a new technique called next-generation sequencing (NGS) to monitor circulating cell-free DNA (ctDNA) in children with a type of cancer known as pediatric ...

Recruiting

Type: observational Locations: Guangzhou, , China

The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies

NCT ID: NCT07020260

The PACMAN-Hu19 trial is a study looking at a new type of treatment called CAR T-cell therapy for children and young adults with certain types of leukemia and lymphoma that have not responded to ot...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Utrecht, , Netherlands, Utrecht, , Netherlands

Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma

NCT ID: NCT05346809

This clinical trial is studying a treatment called Isatuximab to see if it can help boost the immune system in patients with multiple myeloma or lymphoma after they receive a stem cell transplant. ...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Detroit, Michigan, United States

A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma

NCT ID: NCT05683171

This clinical trial is studying a new combination of treatments for patients with follicular lymphoma, a type of cancer that affects the lymphatic system. The researchers want to find the best dose...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

NCT ID: NCT07013435

This clinical trial is looking to see if a special program designed to build resilience—helping people cope better with stress and challenges—can improve the quality of life for survivors of lympho...

Not yet recruiting

Phase: NA Type: interventional Locations: Boston, Massachusetts, United States

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

NCT ID: NCT07014293

This clinical trial is looking at whether a special program, called a mind-body resilience group, can help people who have survived lymphoma cope better with the challenges they face after finishin...

Not yet recruiting

Phase: NA Type: interventional Locations: Boston, Massachusetts, United States

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

NCT ID: NCT06680661

The ABBA CORD clinical trial is designed to test whether adding a medication called abatacept to standard treatments can help prevent a serious complication known as acute graft versus host disease...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cleveland, Ohio, United States

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

NCT ID: NCT06326463

This clinical trial is studying a new treatment called CAR T-cell therapy specifically for young patients (up to 21 years old) who have certain hard-to-treat blood cancers, such as acute myelogenou...

Recruiting

Phase: PHASE1 Type: interventional Locations: Memphis, Tennessee, United States

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

NCT ID: NCT06218602

This clinical trial is exploring whether fecal microbiota transplantation (FMT) can help lymphoma patients who are experiencing gut-related side effects from antibiotics used during their treatment...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

NCT ID: NCT05223413

This clinical trial is looking at a method called Remote Ischaemic Preconditioning (RIPC) to see if it can help protect the hearts of lymphoma patients who are receiving a type of chemotherapy call...

Recruiting

Phase: NA Type: interventional Locations: Madrid, , Spain, Madrid, , Spain +22 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions